136 related articles for article (PubMed ID: 33067822)
1. Production of the next-generation positron nuclide zirconium-89 (
Wang F; Ding J; Guo X; Liu T; Ding L; Xia L; Zhu H; Yang Z
J Labelled Comp Radiopharm; 2021 Jan; 64(1):47-56. PubMed ID: 33067822
[TBL] [Abstract][Full Text] [Related]
2.
Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
[TBL] [Abstract][Full Text] [Related]
3. Standardized methods for the production of high specific-activity zirconium-89.
Holland JP; Sheh Y; Lewis JS
Nucl Med Biol; 2009 Oct; 36(7):729-39. PubMed ID: 19720285
[TBL] [Abstract][Full Text] [Related]
4. Improved production and processing of ⁸⁹Zr using a solution target.
Pandey MK; Bansal A; Engelbrecht HP; Byrne JF; Packard AB; DeGrado TR
Nucl Med Biol; 2016 Jan; 43(1):97-100. PubMed ID: 26471714
[TBL] [Abstract][Full Text] [Related]
5. Production of Zr-89 using sputtered yttrium coin targets
Queern SL; Aweda TA; Massicano AVF; Clanton NA; El Sayed R; Sader JA; Zyuzin A; Lapi SE
Nucl Med Biol; 2017 Jul; 50():11-16. PubMed ID: 28376350
[TBL] [Abstract][Full Text] [Related]
6. Anion exchange and extraction chromatography tandem column isolation of zirconium-89 (
O'Hara MJ; Carter JC; Kellogg CM; Link JM
J Chromatogr A; 2022 Aug; 1678():463347. PubMed ID: 35908511
[TBL] [Abstract][Full Text] [Related]
7. Prediction of (89)Zr production using the Monte Carlo code FLUKA.
Infantino A; Cicoria G; Pancaldi D; Ciarmatori A; Boschi S; Fanti S; Marengo M; Mostacci D
Appl Radiat Isot; 2011 Aug; 69(8):1134-7. PubMed ID: 21146416
[TBL] [Abstract][Full Text] [Related]
8. Modeling and experimental data of zirconium-89 production yield.
Sharifian M; Sadeghi M; Alirezapour B; Yarmohammadi M; Ardaneh K
Appl Radiat Isot; 2017 Dec; 130():206-210. PubMed ID: 28992565
[TBL] [Abstract][Full Text] [Related]
9. Tandem column isolation of zirconium-89 from cyclotron bombarded yttrium targets using an automated fluidic platform: Anion exchange to hydroxamate resin columns.
O'Hara MJ; Murray NJ; Carter JC; Kellogg CM; Link JM
J Chromatogr A; 2018 Sep; 1567():37-46. PubMed ID: 30054129
[TBL] [Abstract][Full Text] [Related]
10. Hydroxamate column-based purification of zirconium-89 (
O'Hara MJ; Murray NJ; Carter JC; Kellogg CM; Link JM
Appl Radiat Isot; 2018 Feb; 132():85-94. PubMed ID: 29172059
[TBL] [Abstract][Full Text] [Related]
11. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of
Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566
[TBL] [Abstract][Full Text] [Related]
12. Effective dose to staff members in a positron emission tomography/CT facility using zirconium-89.
Alzimami KS; Ma AK
Br J Radiol; 2013 Oct; 86(1030):20130318. PubMed ID: 23934963
[TBL] [Abstract][Full Text] [Related]
13. Site-specifically labeled
Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
[TBL] [Abstract][Full Text] [Related]
14. Light-Induced Radiosynthesis of
Klingler S; Fay R; Holland JP
J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
[TBL] [Abstract][Full Text] [Related]
15. Fully Automated
Poot AJ; Adamzek KWA; Windhorst AD; Vosjan MJWD; Kropf S; Wester HJ; van Dongen GAMS; Vugts DJ
J Nucl Med; 2019 May; 60(5):691-695. PubMed ID: 30530830
[TBL] [Abstract][Full Text] [Related]
16. A radiopharmaceutical [
Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N
Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708
[TBL] [Abstract][Full Text] [Related]
17. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
Al-Saden N; Lam K; Chan C; Reilly RM
Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
19. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
[TBL] [Abstract][Full Text] [Related]
20. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
